These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7579591)

  • 1. Bile acids as drugs: principles, mechanisms of action and formulations.
    Hofmann AF
    Ital J Gastroenterol; 1995 Mar; 27(2):106-13. PubMed ID: 7579591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute changes of bile acid pool composition on biliary lipid secretion.
    Carulli N; Loria P; Bertolotti M; Ponz de Leon M; Menozzi D; Medici G; Piccagli I
    J Clin Invest; 1984 Aug; 74(2):614-24. PubMed ID: 6746909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
    Miettinen TE; Tarpila S; Gylling H
    Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G; Beuers U
    Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
    Stiehl A
    Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
    Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Density and chemical solubility of cholesteric biliary calculi by cholelytic preparations of bile acids (CHENO-USO FALK) in vitro].
    Mansurov KhKh; Dzhuraev KhSh; Merkul'eva NR
    Ter Arkh; 1986; 58(6):102-4. PubMed ID: 3764702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrograde ileal bile acid tolerance test--experimental and clinical study].
    Taruishi M; Ashida T; Shibata Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):574-83, 585. PubMed ID: 7927182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
    Campana G; Pasini P; Roda A; Spampinato S
    Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat.
    Holzinger F; Schteingart CD; Ton-Nu HT; Eming SA; Monte MJ; Hagey LR; Hofmann AF
    Hepatology; 1997 Nov; 26(5):1263-71. PubMed ID: 9362371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids: trying to understand their chemistry and biology with the hope of helping patients.
    Hofmann AF
    Hepatology; 2009 May; 49(5):1403-18. PubMed ID: 19296471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.